Citation

Dikmen RD, Yildiz EAB, Şahin A (2023) Pregnancy Symptoms and COVID-19 Fear Experienced by Pregnant Women. Int J Womens Health Wellness 9:147. doi.org/10.23937/2474-1353/1510147

Original Article | OPEN ACCESS DOI: 10.23937/2474-1353/1510147

Pregnancy Symptoms and COVID-19 Fear Experienced by Pregnant Women

Rukiye Demir Dikmen1*, Elif Ayfer Baltaci Yildiz2 and Aycan Şahin3

1Lecturer, Principles of Nursing Department, Bingol University -Vocational School of Health Services, Turkey

2Lecturer, Women's Health and Diseases Nursing Department, Bingol University - Vocational School of Health Services, Turkey

3PhD Student, Nursing Department, Hasan Kalyoncu University, Turkey

Abstract

Purpose

This research was executed in order to designate the level of symptoms pregnant women experience, and the link between COVID-19 fear and pregnancy symptoms.

Material and method

A questionnaire was carried out on women 12-40 weeks pregnant who consulted Bingöl Maternity and Children Hospital between 11 February-1 July 2022. Data were obtained by "Sociodemographic Form", "Pregnancy Symptom Inventory (PSI)" and "COVID-19 Fear Scale’’. The research was completed with 390 pregnant women.

Findings

It was determined that frequently encountered 5 symptoms pregnant women experience are firstly thamuria, secondly fatigue or weakness, thirdly sleep deprivation, fourthly increase in vaginal secretion, and fifthly backache. It was also observed that there was a positive relationship between PSI and its impact on daily life, and a positive relationship between fear of COVID-19 and pregnancy symptoms. Moreover, a positive relationship between COVID-19 and its impact on daily life was observed. Weight, gestational week, and regular controls were found to be statistically significant for PSI. It was determined that COVID-19 fear and the number of births are worthwhile.

Outcome

Pregnancy symptoms of expectant mothers are effective in limiting life. The fear of the COVID-19 pandemic influences the level of pregnancy symptoms.

Keywords

Pregnant woman, Pandemic, Pregnancy symptoms

Introduction

World Health Organization (WHO) declared coronavirus illness (COVID-19) as a pandemic in March 2020 [1]. The widespread and transformation of COVID-19 into a pandemic have caused stress, fear, and anxiety in individuals [2,3]. Naturally, one of the psychological aspects of the COVID-19 pandemic is fear [4]. It is crucial to comprehend the impact of fear on the mental health of individuals [5]. Patients who are diagnosed positive and treated due to the effect of fear caused by COVID-19, as well as their families and all individuals contacted with them, may experience social exclusion. This situation may increase the risk of mental health issues in all individuals, such as adjustment disorder and depression [6,7].

Fear is a defense mechanism that is necessary for the survival of living things and supports adaptation. It is acknowledged that fear which becomes chronic can cause mental disorders along with harming individuals in multiple ways [8,9]. There are pregnant women among the groups who are vulnerable to viral infections and the consequences of these infections [10]. Situations such as high levels of stress, emergencies, and natural disasters can increase the risk of mental illness in pregnant women during pregnancy. Therefore, it can be assumed that pregnant women are vulnerable to mental and psychological health problems during the COVID-19 outbreak [11]. The prevalence of such diseases increases the concerns and fears of pregnant women about the health of themselves and their babies [12].

In addition to the metabolic requirements, the developmental needs of the foetus also increase during pregnancy. Anatomical, immunological, and physiological changes occur in the pregnancy process [13]. Increased oxygen demand, increase in the diaphragm, increased abdominal pressure, decreased lung capacity, decreased compliance of chest wall, oedema of respiratory mucous, and inability to clear the secretions in the respiratory tract reduce the hypoxia tolerance of the pregnant and may lead to a faster progression to respiratory failure [14,15]. Evidence-based information about a new disease, COVID-19, is limited in pregnant women [13]. A study conducted in the United States with 2740 pregnant women during COVID- 19 pandemic period (2020) found that the pandemic increases pregnancy anxiety and significantly affects the mental health of the participating individuals [16]. We did not find a study in which pregnancy symptoms and fear of COVID -19 were studied together in our literature review. We think it was the first in the region where the study took place. The aim of this study, which was carried out during the pandemic, is to determine the link between the symptom levels experienced by pregnant women and fear of restricting life, and fear of COVID-19.

Material and Method

Between 12 and 40 weeks pregnant women who do not have chronic illnesses were included in the research. Ones with communication disorders, illiteracy, and receiving treatment for psychiatric disorders were excluded from the study. It took approximately 20 minutes to interview a pregnant woman. Before the research, it was informed that the participation was voluntary, and participants could stop answering the questionnaire as the conversation was ongoing if they wanted to. The data were collected by the researchers through face-to-face interviews with pregnant women at the hospital between 11 February and 1 July 2022. The research was completed with 390 pregnant women. 13 questionnaire forms that were abandoned or filled incompletely were not included in the study.

Data collection tools

Sociodemographic form: It consisted of 12 articles about age, height, weight, pregnancy week, number of pregnancies, number of births, whether the pregnancy was planned or not, attendance to regular check-ups, professional status, level of education of pregnant women, and professional status and level of education of their partner.

Pregnancy Symptom Inventory (PSI): It was developed by Foxcroft, et al. (2013) to assess the frequency of symptoms experienced during pregnancy and the level of limitation of symptoms on daily life activities [17]. PSI is a two-section scale that evaluates 42 common symptoms in pregnancy. While the maximum score that can be achieved from the first section of PSI is 166, the minimum is 0. Each statement is evaluated between 0 and 3. The increase in the score from the first section of the PSI represents the increase in the frequency of the symptoms experienced. The second section of PSI assesses the level of limitation of symptoms on daily life activities. This section is triple likert. Each statement is evaluated between 1 and 3. While the maximum score that can be achieved from the second section of PSI is 126, the minimum is 42. The increase in the score from the second section of the PSI represents the increase in the level of limitation of symptoms in daily life. Turkish validity and reliability of the scale were conducted by Gürkan ve Güloğlu (2020). The Cronbach Alpha coefficient is 0.82 [18]. In this research, the Cronbach Alpha value was determined as 0.81.

Covid-19 fear scale: COVID-19 Fear Scale was developed by Ahorsu, et al. (2020). It consists of 7 statements, all collected in one dimension. Scale statements are quintet likert. Each statement is listed from "1 - Strongly Disagree" to "5 - Strongly Agree. High scores on the scale indicate increased COVID-19 fear level. The Cronbach Alpha coefficient of the original scale is 0.82 [3]. The adaptation of the COVID-19 Fear Scale to Turkish was made by Artan, et al. (2021). The Cronbach Alpha coefficient of the scale is 0.86 [19]. In this research, the Cronbach Alpha value was determined as 0.90.

Ethical permissions: Prior to the research, ethics committee approval granted by Bingöl University Health Sciences Scientific Research and Publication Ethics Board, and (Date: 24.01.2022 Number: E-33117789-044-47213) institutional permission granted by Bingöl Maternity and Children Hospital (Date: 10.02.2022 Number: E-79879538-044-49920) were acquired.

Statistical analysis: SPSS 25.0 was used in order to analyze the data of this research. Primarily, reliability analysis was performed. Then the percentage, the frequency, the Anova, T-test, the correlation, and regression tests were performed. Post-Hoc tests were used to determine between which groups the significance was.

Findings

It was found that, with regard to ages of pregnant women participating in the research, 82 individuals (21.0%) were between 18-24, 157 individuals (40.3%) were between 25-30, 105 individuals (26.9%) were between 31-36, 34 individuals (8.7%) were between 37-40, and 12 individuals (3.1%) were 41 and above. 184 (47.2%) participants were between 71-90 kg, while 180 (46.2%) of them were between 50-70 kg. When whether the current pregnancy was planned or not is asked, it was determined that 260 (66.7%) of pregnancies were planned, and 130 (33.3%) were unplanned pregnancies. It was determined that 257 (65.9%) participants gave birth between 1-3, 90 (23.1%) gave birth between 4-6, and 43 (11.0%) gave 7 or more births. In the event of regular pregnancy check-up visits, it was determined that 351 (90.0%) people went to regular check-ups, and 39 (10.0%) people did not. It was found that 151 (38.7%) of the participants were primary school graduates. It was determined that 347 (89.0%) women were unemployed and 43 (11.0%) were employed. It was determined that the partners of 317 (81.3%) women were working and the partners of 73 (18.7%) women were not working. It was also determined that the partners of 114 (29.2%) women were high school graduates (Table 1).

Table 1: Descriptive statistics on participants' demographic variables. View Table 1

When the prevalences of symptoms in the PSI were inspected, it was determined that frequently encountered 5 symptoms pregnant women experience are firstly thamuria, secondly fatigue or weakness, thirdly sleep deprivation, fourthly increase in vaginal secretion, and fifthly backache. It was determined that occasionally encountered symptoms are firstly food craving, secondly headache, thirdly fatigue or weakness, fourthly stretch marks on abdomen and thighs, and fifthly dry mouth (Table 2).

Table 2: Prevalence of symptoms included in the Pregnancy Symptom Inventory (PSI). View Table 2

According to the correlation analysis between the effect of PSI on daily life and fear of COVID-19; it was determined that there was a positive relationship between PSI and the effect on daily life. Also, there was a positive relationship between COVID-19 fear and pregnancy symptoms. In addition, it was determined that there was a positive relationship between the fear of COVID-19 and the impact on everyday life (Table 3).

Table 3: Effect of pregnancy symptoms on daily life and relationship with fear of Covid-19. View Table 3

According to the results of the Schfee Post-Hoc test performed to unearth from which group this difference occurs, it was revealed that individuals with a weight of 50-70 kg experienced fewer symptoms than those who were overweight. The difference between pregnancy week and PSI was determined, however, it did not show any difference with the fear of COVID-19. According to the result of the Schfee Post-Hoc test performed to unearth from which group this difference occurs, it was revealed that 12-18 weeks pregnant women experienced fewer symptoms compared to 37-40 weeks. It was seen that there was not any difference between the number of pregnancies and the fear of PSI and COVID-19. While it was determined that there was not any difference between the number of births and PSI, it was determined that this situation was the opposite between the fear of COVID-19 and the number of births. According to the Scheffe Post-Hoc test, it was determined that individuals who do not have children have lower fear than those who have 4-6 children (Table 4).

Table 4: Anova analysis results of demographic variables of pregnant women and their spouses. View Table 4

Likewise, there was not any statistically significant difference between the working status of the partners of participants and the fear of PSI and COVID-19. It was found that there was a significant difference between regular check-up status and PSI. Even though, there was no difference between the fear of COVID-19 and the status of going to regular check-ups (Table 5).

Table 5: T-Test analysis results of demographic variables of pregnant women and their spouses. View Table 5

Discussion

Women who are pregnant experience numerous physical symptoms due to natural physiological changes [17]. The findings of this study, which examined the frequency of pregnancy symptoms during the pandemic process, the effects of these symptoms on daily life restriction, and COVID-19 fear, were discussed with the literature. It was seen that 67.9% of the participating pregnant women frequently experienced the symptoms of fatigue and weakness. Foxcroft, et al. (2013) found the rate of experiencing fatigue and weakness symptoms as 45.5% in their study with the participation of 211 pregnant women [17]. In a study conducted in Turkey, it was seen that fatigue and weakness symptoms were experienced frequently at a rate of 30.9%. [20]. The fact that 89% of the participants were housewives and that, culturally, women are responsible for taking care of children and other housecare may affect fatigue levels. It was designated that the frequently confronted symptoms are nausea in 43.6% (139 people), reflux symptom in 44.9%, and dry mouth symptom in 34.1% (133 people). Also, in a study, it was found that the symptoms of nausea were experienced in 34.4%, reflux symptoms in 29.6%, and dry mouth symptoms in 32.8% [17]. In a study conducted with pregnant women in Turkey (2017), it was found that the symptoms of nausea in 15.5% and reflux in 30.9% were experienced frequently [20].

Urinary symptoms in pregnant women are highly encountered [21]. Studies show that the prevalence of urinary symptoms in pregnancy is between 63% and 80% [22,23]. In our study, the rate of those who experienced frequent thamuria was 74.1%, while this rate was 87.7% in total. In pregnant women, Coşar Çetin, et al. reported the frequency of thamuria symptoms as 93.9%, and Foxcroft, et al. 85.2% [17,20]. In this study, it was seen that 37.7% (147 people) of pregnant women frequently experienced the symptom of feeling depressed and 34.4% had frequent anxiety symptoms. A study fulfilled in the United States (2020) inquired depression status of pregnant women who are between 6-14 and 22-30 weeks pregnant. This study, which tracks postconception depression status as well, concluded that women whose depression status increase as pregnancy carries on, have more possibility to give premature birth [24]. In a study conducted with 298 pregnant women (2020), it was seen that 82 pregnant women experienced various levels of anxiety and 93 pregnant women experienced various levels of depression. [25]. In this study, which was conducted during the period of partial isolation related to the pandemic, the psychological effects of the disease on pregnant women may have affected the result. In addition, the fact that the current pregnancy of 33.3% of pregnant women was not planned might have increased their concerns.

In this study, it was determined that pregnant women experienced the symptom of increased vaginal discharge in a total of 76.9% and frequently in 61.3%. In similar studies, this rate was found to be 86.4% and 49.8% [17,20]. Also, it was found that 58.2% of the participants had frequent back pain and 46.9% (183 people) had frequent hip or pelvis pain. In the study of Foxcroft, et al., these rates were 19.5% and 10.6%, respectively [17]. In a study, it was seen that pregnant women frequently experience back and low back pain at a rate of 41.5% [20]. It is estimated that the prevalence of pregnancy-related back pain, which is a significant health problem related to pregnancy, is over 50% [26,27]. Pregnancy is a risk factor for leg cramps [28]. Leg cramps can lead to severe pain and sleep deprivation. Sleep deprivation can prevent daily activities from being carried out and makes pregnancy difficult [29].

Suggestions

This research revealed that the coronavirus pandemic has affected pregnancy processes, lives, and routines of pregnant women. Women are vulnerable especially during pregnancy. Measures that support the psychological health of pregnant women should be considered. Careful monitoring of both physiological and psychological needs of mothers especially for this period and reducing their anxiety and stress by informing expectant mothers will contribute positively to the birth process and the postpartum period.

Both pregnant women and healthcare professionals can help women to make small lifestyle changes by setting common goals, reminders, and feedback. Strategies should be sought to improve collaboration between all health care professionals involved in regular antenatal care and pregnant women.

References

  1. World Health Organization (2020) Rolling updates on coronavirus disease (COVID-19).
  2. Ahorsu DK, Imani V, Lin CY, Timpka T, Brostrom A, et al. (2020) Associations between fear of COVID-19, mental health, and preventive behaviours across pregnant women and husbands: An actor-partner interdependence modelling. Int J Ment Health Addict 20: 68-82.
  3. Ahorsu DK, Lin CY, Imani V, Saffari M, Griffiths MD, et al. (2022) The fear of COVID-19 scale: development and initial validation. Int J Ment Health Addict 20: 1537-1545.
  4. Pakpour AH, Griffiths MD (2020) The fear of COVID-19 and its role in preventive behaviors. J Concurrent Disorders 2: 58-63.
  5. Xiang YT, Yang Y, Zhang L, Zhang G, Cheung T (2020) Timely mental health care for the 2019 novel coronavirus outbreak is urgently needed. Lancet Psychiatry 7: 228-229.
  6. Amin S (2020) The psychology of coronavirus fear: Are healthcare professionals suffering from corona-phobia? Int J Healthcare Manag 13: 249-256.
  7. Zhang G, Wu W, Zhao X, Zhang L (2020) Recommended psychological crisis intervention response to the 2019 novel coronavirus pneumonia outbreak in China: A model of West China Hospital. Precis Clin Med 3: 3-8.
  8. Garcia R (2017) Neurobiology of fear and specific phobias. Learning & Memory 24: 462-471.
  9. Shin LM, Liberzon I (2010) The neurocircuitry of fear, stress, and anxiety disorders. Neuropsychopharmacology 35: 169-191.
  10. Rasmussen SA, Smulian JC, Lednicky JA, Wen TS, Jamieson DJ (2020) Coronavirus disease 2019 (COVID-19) and pregnancy: What obstetricians need to know. Am J Obstet Gynecol 222: 415-526.
  11. Thapa SB, Mainali A, Schwank SE, Acharya G (2020) Maternal mental health in the time of the COVID-19 Pandemic. Acta Obstet Gynecol Scand 99: 817-818.
  12. Mirzadeh M, Khedmat L (2020) Pregnant women in the exposure To COVID-19 infection outbreak: The unseen risk factors and preventive healthcare patterns. J Matern Fetal Neonatal Med 35: 1377-1378.
  13. Pountoukidou A, Potamiti-Komi M, Sarri V, Papapanou M, Routsi E, et al. (2021) Management and prevention of COVID-19 in pregnancy and pandemic obstetric care: A review of current practices. Healthcare (Basel) 9: 467.
  14. Beigi RH (2017) Emerging infectious diseases in pregnancy. Obstet Gynecol 129: 896-906.
  15. Young G (2015) Leg cramps. BMJ Clin Evid 2015: 1113.
  16. Tan EK, Tan EL (2013) Alterations in physiology and anatomy during pregnancy. Best Pract Res Clin Obstet Gynaecol 27: 791-802.
  17. Moyer CA, Compton SD, Kaselitz E, Muzik M (2020) Pregnancy-related anxiety during COVID-19: A nationwide survey of 2740 pregnant women. Arch Womens Ment Health 23: 757-765.
  18. Foxcroft KF, Callaway LK, Byrne NM, Webster J (2013) Development and validation of a pregnancy symptoms inventory. BMC Pregnancy Childbirth 13: 2-9.
  19. Gürkan CÖ, Güloglu EZ (2020). Gebelik Semptom Envanteri’nin Türkçe geçerlilik ve güvenilirlik çalismasi. ACU Saglik Bil Dergisi 11: 298-303.
  20. Artan T, Meydan S, Irmak SE (2021) Turkish version of the fear of COVID-19 Scale: Validity and reliability study. Arch Health Sci Res 8: 117-123.
  21. Cosar Cetin F, Demirci N, Yesilçiçek Çalik K, Çil Akinci A (2017) Ordinary physical complaints in pregnancy. 48: 135-141.
  22. Dinc A (2018) Prevalence of urinary incontinence during pregnancy and associated risk factors. Low Urin Tract Symptoms 10: 303-307.
  23. Martins G, Soler ZA, Cordeiro JA, Amaro JL, Moore KN (2010) Prevalence and risk factors for urinary incontinence in healthy pregnant Brazilian women. Int Urogynecol J 21: 1271-1277.
  24. Balik G, Guven ES, Tekin YB, Senturk S, Kagitci M, et al. (2016) Lower urinary tract symptoms and urinary incontinence during pregnancy. Low Urin Tract Symptoms 8: 120-124.
  25. Miller ES, Saade GR, Simhan HN, Monk C, David MH, et al. (2022) Trajectories of antenatal depression and adverse pregnancy outcomes. Am J Obstet Gynecol 226: 108.e1-108.e9.
  26. Cao Y, Liu J, Zhang Y, Li Y, Chen Z, et al. (2021) Pregnant women's psychological state and influence factors: anxiety, and depression during COVID-19 outbreak. J Perinat Med 49: 664-673.
  27. Hoy D, Bain C, Williams G, March L, Brooks P, et al. (2012) A systematic review of the global prevalence of low back pain. Arthritis Rheum 64: 2028-2037.
  28. Gutke A, Boissonnault J, Brook G, Stuge B (2018) The severity and impact of pelvic girdle pain and low-back pain in pregnancy: A multinational study. J Womens Health (Larchmt) 27: 510-517.
  29. Lee KA, Gay CL (2004) Sleep in late pregnancy predicts length of labor and type of delivery. Am J Obstet Gynecol 191: 2041-2046.

Citation

Dikmen RD, Yildiz EAB, Şahin A (2023) Pregnancy Symptoms and COVID-19 Fear Experienced by Pregnant Women. Int J Womens Health Wellness 9:147. doi.org/10.23937/2474-1353/1510147